MedPath

Chronic Insertional Achilles Tendonitis Treated With or Without Flexor Hallucis Longus Tendon Transfer

Phase 4
Completed
Conditions
Chronic Insertional Achilles Tendonitis
Registration Number
NCT00950053
Lead Sponsor
OrthoCarolina Research Institute, Inc.
Brief Summary

The purpose of this study is to determine whether Achilles tendon debridement and decompression augmented with flexor hallucis longus (FHL) tendon transfer results in improved clinical and functional outcome as measured by ankle plantar flexion strength and American Orthopedic Foot and Ankle Society (AOFAS) score compared to debridement and decompression alone in patients over 50 years of age with chronic insertional Achilles tendinosis.

H0: There will be no difference in ankle plantar flexion strength measured using a handheld dynamometer between patients randomized to achilles tendon decompression and debridement alone (Group 1) and patients randomized to achilles tendon decompression and debridement augmented with FHL transfer (Group 2).

HA: Patients randomized to achilles tendon decompression and debridement alone (Group 1) will have less ankle plantar flexion strength compared to patients randomized to achilles tendon decompression and debridement augmented with FHL transfer (Group 2).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Patients 50 years of age or older
  • Patients diagnosed with chronic insertional Achilles tendonitis
  • Failed greater than 3 months of conservative treatment (activity and shoe modification, heel lifts, non-steroidal anti-inflammatory medications, stretching exercises, and formal physical therapy)
Exclusion Criteria
  • Patients less than 50 years of age upon presentation
  • Females of child-bearing potential
  • Patients who have a history of ipsilateral Achilles tendon rupture
  • History of infection in the same lower extremity
  • Patients unable to undergo MRI scan

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
ankle plantar flexion strength measured using a handheld dynamometerpre-operatively, 3 months, 6 months, and 1 year
Secondary Outcome Measures
NameTimeMethod
American Orthopaedic Foot and Ankle Society(AOFAS) Ankle-Hindfoot scorepre-operatively, 3 months, 6 months, and 1 year
Visual analog pain scale (VAS)pre-operatively, 3 months, 6 months, and 1 year
Hallux plantarflexion strength using the dynamometerpre-operatively, 3 months, 6 months, and 1 year
Patient Satisfaction1 year
Surgical complicationsDate of Surgery
Postoperative complications3 months, 6 months, and 1 year

Trial Locations

Locations (1)

OrthoCarolina, PA

🇺🇸

Charlotte, North Carolina, United States

OrthoCarolina, PA
🇺🇸Charlotte, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.